Edition:
United States

IHH Healthcare Bhd (IHHH.KL)

IHHH.KL on Kuala Lumpur Stock Exchange

5.80MYR
26 Jun 2019
Change (% chg)

RM0.02 (+0.35%)
Prev Close
RM5.78
Open
RM5.79
Day's High
RM5.83
Day's Low
RM5.73
Volume
4,452,400
Avg. Vol
5,980,896
52-wk High
RM6.13
52-wk Low
RM4.54

Summary

Name Age Since Current Position

Mohammed Azlan bin Hashim

62 2018 Independent Non-Executive Chairman of the Board

See Leng Tan

53 2014 Chief Executive Officer, Managing Director, Non-Independent Executive Director

Soon Teck Low

53 2016 Group Chief Financial Officer

Aziz Baba Abdul

62 2016 Chief Executive Officer and Vice-Chancellor, IMU Health Sdn Bhd

Suet Wun Lim

57 2018 Chief Operating Officer

Fay Lin Teo

2017 Group Chief Operating Officer

Siew Kin Hoon

54 Group Head - Risk Governance

Audrey Huang

62 2013 Group Head - Internal Audit

Bhagat Chintamani Aniruddha

48 2016 Non-Independent Non-Executive Director

Mehmet Ali Aydinlar

62 2019 Non-Independent Non-Executive Director

Koji Nagatomi

57 2017 Non-Independent Non-Executive Director

Takeshi Saito

47 2019 Non-Independent Non-Executive Director

Shirish Apte

2014 Independent Non-Executive Director

Rossana Annizah binti Ahmad Rashid

52 2012 Non-Executive Independent Director

Pei Lynn Quek

45 2016 Non-Independent, Non-Executive Director

Jill Watts

59 2018 Non-Executive Independent Director

Penelope Koh

Assistant Vice President - Investor Relations

Biographies

Name Description

Mohammed Azlan bin Hashim

Dato' Mohammed Azlan bin Hashim has been re-designated as an Independent Non-Executive Chairman of the Board of the Company. He currently serves as Non-Independent Non-Executive Deputy Chairman of the Board of IHH Healthcare Berhad. Prior to his appointment as Deputy Chairman on IHH Healthcare Berhad's ("IHH") Board of Directors in 2011, Dato' Mohammed Azlan bin Hashim was the Executive Chairman of the (then) Kuala Lumpur Stock Exchange Group from 1998 to 2004. He also serves on the Boards and certain Board Committees of IHH subsidiaries, namely Parkway Pantai Limited and Acibadem Saglik Yatirimlari Holding A.S. Group. Dato' Azlan began his career as an auditor at Peat Marwick, Mitchell & Co in Australia and thereafter served in various senior management roles at Amanah-Chase Merchant Bank Berhad, Sapura Holdings Sdn Bhd, Bumiputra Merchant Bankers Berhad, Kumpulan Fima Berhad and Amanah Capital Malaysia Berhad.

See Leng Tan

Dr. Tan See Leng is Chief Executive Officer, Managing Director, Non-Independent Executive Director of IHH Healthcare Berhad., since January 1, 2014. Dr Tan See Leng was appointed the Managing Director and Chief Executive Officer of IHH Healthcare Berhad (“IHH”) in January 2014 after serving as an Executive Director on the IHH Board for two years. Dr Tan is also the Group CEO and Managing Director of Parkway Pantai Limited, a position he assumed in 2011. He also serves on the Boards of IHH subsidiaries, namely Parkway Pantai Limited, IMU Health Sdn Bhd and Acibadem Saglik Yatirimlari Holding A.S. (“ASYH”) Group and a Board Committee of ASYH. Prior to this, Dr Tan was the CEO of Parkway Holdings Limited from April 2010, a position he rose to fairly quickly after he joined Parkway in 2004 as Chief Operating Officer of Mount Elizabeth Hospital. As a young entrepreneur, Dr Tan founded a private primary healthcare group at the age of 27 and subsequently developed it into the second largest primary healthcare group in Singapore before successfully selling the company to one of the leading global health-plan providers. With over 27 years of healthcare experience, Dr Tan has served as an active member of various medical committees such as Singapore Ministry of Health’s MediShield Life Review Committee. Academic / Professional Qualification(s) • Bachelor of Medicine and Bachelor of Surgery (MBBS), National University of Singapore • Master of Medicine (Family Medicine), National University of Singapore • Master of Business Administration, University of Chicago Booth School of Business • Fellow, Academy of Medicine, Singapore • Fellow, College of Family Physicians, Singapore.

Soon Teck Low

Mr. Low Soon Teck is Group Chief Financial Officer at IHH Healthcare Berhad., since January 10, 2016. He holds Master of Business Administration, The University of Chicago Booth School of Business (2004) and LLB (Hons)(2nd Upper), National University of Singapore (1990). He was admitted as Solicitor of England and Wales in 1995 and as Advocate and Solicitor of Singapore in 1991. He is Member of Law Society of England and Wales. Low Soon Teck, practised as a solicitor in Singapore at a boutique firm from 1991 to 1993, focusing on corporate and banking laws. Mr. Low then joined the Kuok/Kerry Group in 1994, based in Hong Kong holding various senior positions in different businesses within the Kuok/Kerry Group including as the Director of China Operations at SCMP Group, publisher of the South China Morning Post, where he was responsible for business development, newspaper publishing and circulation operations, and managing a chain of retail convenience stores. Mr. Low relocated to Singapore in 2005, as the Group Financial Controller of Kuok Oils and Grain Pte Ltd, which was subsequently merged with Wilmar International Limited in 2006. At Wilmar International Limited, he held the position of Group Treasurer until 2009. He was then appointed Chief Financial Officer of PACC Offshore Services Holdings Group, the offshore marine arm of the Kuok/ Kerry Group. In 2013, he joined RCMA Group, a commodities supply chain management company as Chief Financial Officer, a position that he held until 2015. He has over 20 years of experience in finance, legal and general management at leadership roles.

Aziz Baba Abdul

Prof. Abdul Aziz Baba is Chief Executive Officer and Vice-Chancellor, IMU Health Sdn Bhd of the Company. Before he joined IMU in July 2013 as Professor of Medicine, Prof Aziz held several key academic administrative positions at the School of Medical Sciences (SMS) of Universiti Sains Malaysia (USM). These included the positions of Dean (2005- 2012) and Deputy Dean (2003-2005). Preceding this he served as a Professor (2000), Associate Professor (1992) and a Lecturer and Clinical Haematologist/ Oncologist at USM’s SMS following the completion of his postgraduate training in 1986. During his tenure with USM, Prof Aziz was instrumental in establishing the Clinical Haematology and Stem Cell Transplantation service at USM’s teaching hospital, HUSM. Prof Aziz undertook his undergraduate medical training at the University of Melbourne on a Colombo Plan scholarship and graduated in November 1979. He subsequently trained in Internal Medicine, Haematology and Medical Oncology at several leading overseas institutions in Singapore, Scotland and in Melbourne, Australia. His past national appointments include that of President of the Malaysian Society of Haematology, Chairman of the National Conjoint Board for Postgraduate Medical Programmes, as well as Chairman of the Specialist Advisory Committee (Clinical Haematology) of the National Specialist Register. Prof Aziz has also been a member of the Malaysian Medical Council (MMC) and has served the MMC on several accreditation visits to local and foreign medical institutions. Currently he serves as a member of the Joint Technical Committee of the Malaysian Medical Council and the Executive Committee of the National Cancer Council Malaysia (MAKNA). Academic / Professional Qualification(s) • Bachelor of Medicine and Bachelor of Surgery (MBBS), University of Melbourne, Australia.

Suet Wun Lim

Dr. Suet Wun Lim is Chief Operating Officer of the Company. He was Group Chief Operating Officer, Parkway Pantai Limited of the Company. Dr Lim Suet Wun is the Group Chief Operating Office of Parkway Pantai Limited, an indirect wholly-owned subsidiary of IHH Healthcare Berhad. He brings more than 30 years of experience in healthcare management. Dr Lim has served Parkway Pantai since 2011, first as Executive Vice President Singapore, then as the Chief Executive Officer, Parkway Operations Division, before assuming the role of Group COO of Parkway Pantai. Prior to joining Parkway, Dr Lim was the CEO of the National Healthcare Group and Tan Tock Seng Hospital (TTSH). In 2003, Dr Lim led the TTSH team through the SARS crisis, when the hospital was designated the SARS hospital for the whole of Singapore. For his leadership, he was awarded the Public Service Star by the President of Singapore. Dr Lim was also the former chairman of the Board of the Joint Commission International (JCI). Academic / Professional Qualification(s) • Bachelor of Medicine and Bachelor of Surgery (MBBS), National University of Singapore • Master of Public Health, University of California, Los Angeles • Master of Business Administration, University of California, Los Angeles.

Fay Lin Teo

Ms. Sharon Teo Fay Lin is Group Chief Operating Officer of the Company. She has been a Human Resources practitioner with more than twenty years’ HR experience across a broad spectrum of pharmaceutical, manufacturing and FMCG MNCs and local enterprises. Prior to joining IHH, Ms Teo served with Avery Dennison Singapore Pte Ltd in various positions, beginning as the HR Director for its’ ASEAN business before leading Integration and Transformation at the East Asia & Pacific level. She was subsequently promoted as the HR Director for the Materials Group at the ASEAN level. Preceding this, Ms Teo held senior positions in pharmaceutical and healthcare MNCs such as Novartis Asia Pacific Pharmaceutical Pte Ltd, where she served as the Human Resources Manager and Regional Human Resources Manager, Asia Pacific before being promoted as the Head of Talent Management, Organization Development & Staffing, Asia Pacific. Prior to that, she served at Bausch & Lomb Sdn Bhd, as the Regional Human Resources Administrator, South Asia before rising to the position of Human Resources & Administration Manager, Malaysia & Singapore. Ms Teo began her career at Yeo Hiap Seng (M) Berhad as a Human Resources Executive in 1993. Academic / Professional Qualification(s) • Bachelor of Arts in Psychology, Anthropology & Sociology, National University of Malaysia • Certificate in Personnel Management, Malaysian Institute of Personnel Management • Leadership Versatility Index Certification and Realise2 Accreditation Programme • DDI Facilitator Certifications (Leadership Assessment and Targeted Selection) • 360° Coaching Accreditation & Occupational Climate Survey.

Siew Kin Hoon

Ms. Hoon Siew Kin (Linda) is Group Head - Risk Governance at IHH Healthcare Berhad. Ms Linda Hoon Siew Kin joined IHH Healthcare Berhad (“IHH”) in June 2015. Her experience gathered over more than 28 years, span the areas of general management, corporate governance, risk management, legal and compliance oversight, insurance procurement, personal data privacy compliance and corporate management. Prior to IHH, Ms Hoon was in National University Health System Pte Ltd (“NUHS”) as Group General Counsel and Board Secretary. At NUHS, she handled legal and risk advisory including overseeing PDPA compliance and actively assisted in the clinical risk management areas of medico-legal claims management. Prior to this, she served as the Group Company Secretary of DBS Group Holdings (listed in Singapore), where she was responsible for handling regulatory compliance and board corporate governance matters. From 1989 to 2005, Ms Hoon served in an engineering services conglomerate, SembCorp Industries Limited (listed in Singapore) and rose to become the Group General Counsel and Group Company Secretary at the corporate office. Academic / Professional Qualification(s) • Bachelor of Laws (Hons) (Second Upper), National University of Singapore • Masters of Law, National University of Singapore • Masters of Science in Management of Health Industries, Essec Business School (Asia Pacific Campus), Singapore • Advocate & Solicitor, Supreme Court of Singapore.

Audrey Huang

Ms. Audrey Huang is Group Head - Internal Audit at IHH Healthcare Berhad since March 1, 2013. She is Fellow member of the Association of Chartered Certified Accountants (UK); Member of the Institute of Singapore Chartered Accountants; Member of the Malaysian Institute of Accountants and Member and Governor of the Institute of Internal Auditors, Singapore. Prior to her appointment as Group Head of Internal Audit of IHH Healthcare Berhad on 1 March 2013, Audrey Huang had been the Head of Internal Audit of Parkway Holdings Limited since 21 February 2005. She was subsequently appointed the Head of Internal Audit of Parkway Pantai Limited upon its incorporation on 21 March 2011. She has more than 30 years of experience in auditing, including external audit experience with one of the Big 4 accounting firms as well as internal audit experience with various financial institutions. She is responsible for managing the internal audit functions of the Group’s overall system of internal controls, risk and governance. In 2013, she obtained the Certification in Risk Management Assurance (“CRMA”) from the Institute of Internal Auditors, Inc USA.

Bhagat Chintamani Aniruddha

Mr. Bhagat Chintamani (Chinta Bhagat) Aniruddha has been Non-Independent Non-Executive Director at IHH Healthcare Berhad since September 23, 2016. He holds Master of Business Administration from INSEAD Business School. He is Executive Director in the Investments Division of Khazanah Nasional Berhad ("Khazanah"). He leads the Mumbai office and is the overseeing executive director for the healthcare sector. Prior to joining Khazanah, Mr Chinta Bhagat spent 14 years at McKinsey & Company in Singapore, including six years as Managing Partner for the Singapore office. Mr Chinta Bhagat was a leader in the Principal Investor practice, serving several sovereign wealth funds, private equity firms, and family owned businesses; as well as a leader in the healthcare practice, serving hospital systems across Asia. Mr Chinta Bhagat also founded and led McKinsey 's corporate governance service line. Prior to joining McKinsey, Mr Chinta Bhagat held various positions at an engineering and construction firm in India, culminating in his role as CEO. Mr Chinta Bhagat is also a qualified architect.

Mehmet Ali Aydinlar

Mr. Mehmet Ali Aydinlar was Non-Independent Non-Executive Director of IHH Healthcare Berhad. He is also a member of the Steering Committee. He holds Business Administration Degree, Galatasaray Economy and Management College. He is the Chairman and Chief Executive Officer of Acibadem Saglik Yatirimlari Holding A.S. as well as the Chairman of the Board of Acibadem group of companies such as A Plus, Acibadem Project Management, Acibadem Mobile Services and Acibadem Labmed. He also serves on the Board of Directors of Parkway Pantai Limited. Mr Aydinlar is currently Chairman of the Turkish Accredited Hospitals Association. A certified public accountant-turned entrepreneur, Mr Aydinlar has been recognised for his extensive experience in management and involvement in the healthcare sector since 1993. In 2006, he was named Male Entrepreneur of the Year in a survey conducted by Ekonomist Magazine and the “Business Executive of the Year” by Dunya Newspaper and Istanbul University’s School of Business Administration. He was also chosen to be “The Person with Most Contribution to Development of Healthcare” by the Turkish Healthcare Volunteers Organisation. He was awarded “The Eminent Services Award of the Grand National Assembly of Turkey” in 2010. In 2013, he was elected the “Businessman of the Year” by Bogazici University, one of the most prestigious higher education institutions in the country and in 2015, he received the “Lifetime Achievement Award” from the same university. He is also the Chairman of the Board of Trustees of Acibadem University. For two years in a row, Mr Aydinlar was recognised by Capital magazine for his philanthropic efforts, as one of the top business people with most charitable donations, ranking at number 5 in 2014. As of 2015, he serves on the board of Foreign Economic Relations Board.

Koji Nagatomi

Mr. Koji Nagatomi is Non-Independent Non-Executive Director of the Company. Appointed to the Board of IHH Healthcare Berhad (“IHH”) on 1 April 2017, Mr Koji Nagatomi currently serves as the Managing Officer and Chief Operating Officer, Healthcare and Service Business Unit of Mitsui & Co., Ltd (“Mitsui”), at its Tokyo Headquarters. Between 2011 and 2015, he served in the position of General Manager for several of Mitsui’s divisions. These included Mitsui’s Planning and Administrative Division (Machinery and Infrastructure), First Projects Development Division and Corporate Communications Division. In May 2008, he was appointed Deputy General Manager of Toyo Engineering Corporation’s Corporate Planning Unit. Preceding his tenure at Toyo Engineering Corporation, Mr Nagatomi served as the General Manager of the Infrastructure Project Development Division of Mitsui & Co. (Asia Pacific) Pte Ltd in Kuala Lumpur from December 2003. Prior to that, Mr Nagatomi joined the Project Development Division of Mitsui’s Indonesia Project Section which was based out of Tokyo. He spent eight years at Mitsui & Co. (USA), Inc in Houston under the Plant & Energy Project Development Department after beginning his professional career in 1986 in Mitsui’s Chemical Plant Division. Academic / Professional Qualification(s) • Master’s Degree, Chemical Engineering, Graduate School of Engineering Science, Osaka University.

Takeshi Saito

Mr. Takeshi Saito is Non-Independent Non-Executive Director of the Company. Mr. Takeshi Saito was alternate director to Mr Koji Nagatomi on the Board of IHH Healthcare Berhad a role he assumed on 1 April 2017. He also serves on the Boards and certain Board Committees of IHH subsidiaries, namely Parkway Pantai Limited (“PPL”) and Acibadem Saglik Yatirimlari Holding A.S. Group. Since March 2017, he has been an Executive Assistant to a Representative Director and Executive Vice President of Mitsui & Co., Ltd (“Mitsui”). Mr. Saito has spent most of his career in the healthcare industry. Preceding his appointment as an Executive Assistant at Mitsui, he was the General Manager of the Provider Network Department, Medical Healthcare Business Division 1, Consumer Service Business Unit of Mitsui between 2015 and 2016. During that time, he also sat on the Board and EXCO of PPL as an alternate director. In 2009, Mr. Saito was seconded to Parkway Group Healthcare as Vice President of Strategic Planning following his appointment as Director of the Medical Healthcare Business Department in Mitsui, where he led the investment in IHH. Prior to this, in 2007, Mr. Saito was appointed Manager of the Strategic Planning/Business Development Department of the Life Science Division at Mitsui, which subsequently became the Medical Healthcare Division in 2008. During this time, Mr. Saito was responsible for the investment in one of the largest pharmacy chains in Japan. He also initiated the 10-year plan for the newly formed Medical Healthcare Division. Mr Saito spent a part of his career in the USA when he was appointed Director of the Corporate Planning Department at Mitsui USA upon completion of his MBA in 2004. He holds Bachelor of Political Science, Keio University, Japan and Master of Business Administration, Kellogg School of Management Northwestern University.

Shirish Apte

Mr. Shirish Moreshwar Apte is appointed as Independent Non-Executive Director of IHH Healthcare Berhad since September 3, 2014. Appointed to the Board of IHH Healthcare Berhad (“IHH”) in 2014, Mr. Shirish Moreshwar Apte is currently also the Independent, Non-Executive, Chairman of Pierfront Mezzanine Fund Pte Ltd. He also serves on the Boards and certain Board Committees of IHH subsidiary, Acibadem Saglik Yatirimlari Holding A.S. He concurrently serves on several Boards of Directors including Commonwealth Bank of Australia, the Supervisory Board of Bank Handlowy, Poland and Fullerton India Credit Company Limited. He is also a Council Member of the Institute of Banking and Finance Singapore. Prior to his retirement from Citigroup in 2014 as Chairman of Asia Pacific Banking, Mr. Apte had built up an impressively extensive 32-year career with Citibank/Citigroup. He held numerous positions with Citibank/ Citigroup serving in Singapore (2011-2013), Hong Kong (2009-2011), London (2003-2009), Poland (1997-2003) and London (1993-1997). He also supervised operations in the Emerging Markets covering Central and Eastern Europe, Middle East, Africa (“CEEMEA”) and Asia Pacific. He was appointed head of Citi’s Corporate and Investment bank in India, CEO for Citibank Poland, and regional CEO first for CEEMEA and then Asia Pacific. Mr. Apte was also a member of Citigroup’s Executive and Operating committees from 2008-2012 and the Group’s Business Practices committee. He began his career in the banking division of Citibank India in 1981. Academic / Professional Qualification(s) • Bachelor of Commerce, Calcutta University • Master of Business Administration - London Business School (Major in Finance) • Institute of Chartered Accountants England - Student contract with Touche Ross (now known as Deloitte).

Rossana Annizah binti Ahmad Rashid

Ms. Rossana Annizah binti Ahmad Rashid is Non-Executive Independent Director of IHH Healthcare Berhad since April 17, 2012. Appointed to the Board of IHH Healthcare Berhad (“IHH”) in 2012, Ms Rossana Annizah binti Ahmad Rashid also serves on the Board and Board Committee of Acibadem Saglik Yatirimlari Holding A.S., an indirect subsidiary of IHH. She is also a Non- Executive Director of Parkway Trust Management Limited (“PTM”), an indirect wholly-owned subsidiary of IHH. PTM manages Parkway Life Real Estate Investment Trust which is listed on the Singapore Exchange Securities Trading Limited. Ms Rossana currently serves as the Deputy Chairman on the Board of Cycle & Carriage Bintang Berhad, a member of the Jardine Matheson Group, as Non-Independent Non-Executive Director subsequent to her appointment as Country Chairman of the Jardine Matheson Group of Companies in Malaysia in 2016. Concurrently, she also serves as a member of the Investment Panel and the Investment Panel Risk Committee of Malaysia’s Employees Provident Fund. In May 2017, she was appointed as an Independent Non-Executive Director of Celcom Axiata Berhad. Prior to her current roles, Ms Rossana was a career professional holding leadership positions in the telecommunications and banking sectors. She previously served in various senior management roles with TIME dotCom Berhad, Maxis Berhad and RHB Bank Berhad, after beginning her banking career with Citibank Malaysia. With a combined 30 years of experience, Ms Rossana has broad experience in business strategy, identifying sustainable monetisation models, understanding customers and competition, as well as the need for reviewing monetisation models focusing on both revenue management and cost management. Academic / Professional Qualification(s) • Bachelor of Arts in Banking and Finance, Canberra College of Advanced Education (now known as the University of Canberra), Australia Present Directorship(s) • Cycle & Carriage Bintang Berhad • Celcom Axiata Berhad.

Pei Lynn Quek

Ms. Pei Lynn Quek Non-Independent, Non-Executive Director of the Company. Ms Quek Pei Lynn is an alternate director to Mr Bhagat Chintamani Aniruddha on the Board of IHH Healthcare Berhad (“IHH”), a role she assumed on 23 September 2016. She also serves on the Boards and certain Board Committees of IHH subsidiaries, namely Parkway Pantai Limited and IMU Health Sdn Bhd. Prior to her current position in IHH, she was appointed alternate director to YM Tengku Dato’ Sri Azmil Zahruddin bin Raja Abdul Aziz on 25 October 2012 and ceased to be his alternate on 23 September 2016 following his resignation as a Director of IHH. Ms Quek also serves as a Director at the Investments Division of Khazanah Nasional Berhad (“Khazanah”), a position she has held since joining the company in 2007. Prior to joining Khazanah, Ms Quek served in the Corporate Finance Division at AmInvestment Bank Berhad for nine years from 1997 to 2006 after beginning her career as an auditor with PriceWaterhouse Coopers in 1994. Bachelor of Economics, Monash University, Australia.

Jill Watts

Ms. Jill Margaret Watts has been Non-Executive Independent Director at the Company since April 4, 2018. Appointed to the Board of IHH Healthcare Berhad (“IHH”) in 2018, Ms Jill Margaret Watts was previously a Director of the Australian Chamber of Commerce, United Kingdom and the Royal Australian Flying Doctor Service, United Kingdom. She also served on several Industry Boards including NHS Partners Network and the Association of Independent Hospital Operators. Ms Watts was the Group Chief Executive Officer of BMI (GHG) Health Care Group (“BMI Healthcare”) in United Kingdom from 2014 to 2017. She has close to 40 years of experience in the healthcare industry and has held a number of senior executive roles in Australia and the United Kingdom. Prior to her appointment at BMI Healthcare, she was the Group Chief Executive Officer of Ramsay Health Care, United Kingdom (“Ramsay UK”) for over six years. She was the Chair of NHS Partners Network between 2009 and 2012, where she was actively engaged in influencing governments on the benefits of having strong and vibrant private healthcare sector. In 2010, Ms Watts was voted as the most influential leader in United Kingdom private healthcare and in 2013 as one of healthcare’s most inspirational women. Under her leadership, Ramsay UK was voted as the best United Kingdom private hospital provider in 2009 and 2013. Academic / Professional Qualification(s) • Registered Nurse, Northwick Park Hospital, London, United Kingdom • Midwifery, Mater Mothers Hospital, Brisbane, Australia • Grad. Dip Health Administration and Information Systems, University of Central Queensland, Australia • Master’s in Business Administration, Griffith University, Queensland, Australia • Wharton Fellow, Pennsylvania University, United States of America.

Penelope Koh